POET
holds · 6.0% allocation
Conviction over time
Sentiment weighted by conviction, oldest to newest — above the line is bullish
Price targets
How each level moved over time. The last value is his current one.
Trades
What he actually did, newest first
-
16 Jul 26
sold, considers it a past mistake
-
16 Jul 26
sold, considers it a past mistake
-
16 Jul 26
bought, considers it a past mistake
-
26 May 26
09/03 call
-
26 May 26
10/03 call
-
26 May 26
11/03 call
-
26 May 26
11/03 call
-
26 May 26
31/03 call
-
26 May 26
31/03 call
-
26 May 26
31/03 call
-
26 May 26
20/04 call
-
26 May 26
27/04, closed the position
-
26 May 26
05/05 call
-
26 May 26
07/05 call
-
08 May 26
Buy at 487 on 09/03
-
08 May 26
Buy at 20 on 10/03
-
08 May 26
Buy at 88.66 on 11/03
-
08 May 26
Buy at 6.52 on 11/03
-
08 May 26
Buy at 4.9 on 31/03
-
08 May 26
Buy at 16.7 on 31/03
-
08 May 26
Buy at 18.7 on 31/03
-
08 May 26
Buy at 230 on 20/04
-
08 May 26
Sold at 8 on 27/04
-
08 May 26
Buy at 36 on 05/05
-
08 May 26
Buy at 16.67 on 07/05
-
01 May 26
sold this month to raise cash
-
01 May 26
sold this month to raise cash
-
01 May 26
sold this month to raise cash
-
01 May 26
only buy made this month
-
01 May 26
wants to add more to bring FTC up from 4.5% allocation, waiting for a better moment to buy
-
27 Apr 26
Decided to sell his POET position after Marvell's contract termination and a four-day delay in disclosure eroded his trust in management.
-
27 Apr 26
Sold entire POET position at $8 after Marvell cancelled its purchase order, securing a 38% profit on a $5.8 average cost.
-
27 Apr 26
Not selling shares despite the drop
-
22 Apr 26
Added to the position, bringing average cost to $5.8.
-
14 Apr 26
loading more POET when it drops below $5.50
-
12 Apr 26
keeps buying below $6
-
11 Apr 26
Plans to keep buying the dips
-
11 Apr 26
Plans to keep buying the dips
-
05 Apr 26
initiated new position
-
05 Apr 26
initiated new position
-
05 Apr 26
initiated new position, up 15% since entry
-
05 Apr 26
initiated new position in SK Hynix
-
05 Apr 26
bought extra shares, continuing to DCA
-
05 Apr 26
plans to add 1 new position as part of concentrating the portfolio
-
05 Apr 26
plans to sell 5 to 6 positions to bring total holdings from 16 down to 11
-
31 Mar 26
one of 3 buys made yesterday
-
31 Mar 26
one of 3 buys made yesterday
-
31 Mar 26
one of 3 buys made yesterday
-
30 Mar 26
added to POET position today
-
11 Mar 26
No further detail given.
-
11 Mar 26
No further detail given.
-
11 Mar 26
No further detail given.
-
11 Mar 26
No further detail given.
-
11 Mar 26
Bought because the $335M cash position limits downside risk.
-
11 Mar 26
Rare asymmetric bet in physical AI; digital lidar paired with high-margin perception software.
-
11 Mar 26
Foundational AI infrastructure play with 62% HBM market share, trading at distressed 5.2x forward P/E.
-
11 Mar 26
Wafer-scale optical interposers replace bottlenecked copper cables; $350M liquidity buffer de-risks the setup.
-
11 Mar 26
Capitalizing on the compute-to-connectivity shift; dominates optical DSP and secures sticky AI silicon revenue.
-
11 Mar 26
Opened position last Monday
Reasoning trail
Every post mentioning POET, newest first — the thesis as it was built and revised
-
16 Jul 26
Defends his long-term thesis despite recent declines, listing cost bases across several holdings, and admits past mistakes (sold CRWD and SIVE, bought POET).
-
02 Jun 26
Suggests that using AI agents to scan X for short reports and going long can beat the market, citing SIVE and POET as recent examples.
-
26 May 26
Clarifies he made two buying calls on $OUST and one on $POET, calculating roughly €1K notional value per call.
-
26 May 26
Recaps a public call track record over ~2.5 months on a hypothetical $1K-per-call basis: buys in SK Hynix, OUST, MRVL, POET (twice), HIMS, Filtronic, WOLF, FLNC, and a sale of POET at 8; reports total invested 10K growing to 18.77K, an 87.70% return.
-
12 May 26
Explains he exited a position (referred to as Poet by the parent) because the thesis broke, and that the replacement stocks he bought instead are performing well; says he doesn't dwell on past decisions.
-
08 May 26
Confirms he is still holding FTC.L (Filtronic) but has exited POET.
-
08 May 26
Recaps a hypothetical $1K-per-decision portfolio of his last 2 months of calls, showing a 53.85% total return across SK Hynix, OUST, MRVL, POET (bought twice, sold), HIMS, Filtronic, WOLF, and FLNC.
-
01 May 26
Speculative reply suggesting LWLG's rally may be capital rotating out of POET rather than fresh conviction.
-
01 May 26
Monthly portfolio update: best month ever at +48.49% return. Raised cash by selling POET, HOOD and CROWD; only buy was FTC (Filtronic). Wants to add to FTC (currently 4.5% allocation) but is waiting for a better entry. 45% of holdings report earnings next week, especially TMDX and FLNC, his worst performers now under 3% allocation each — earnings will decide whether he trims or adds. Plans to move toward a more concentrated ~12-stock portfolio and expects more trading this month.
-
30 Apr 26
Shares and praises another account's post about POET, noting increased attention from Korean accounts on his feed.
-
28 Apr 26
Comments on the parent author's decision to wait a day before closing their POET position, noting it paid off with an extra 6.5% gain.
-
28 Apr 26
States he's soured on POET, saying it's no longer for him after a major revenue miss that he views as showing complete management incompetence; he needs to trust management to build his investment case.
-
28 Apr 26
Explains why Filtronic's post-selloff weakness (driven by ~75% revenue concentration in SpaceX) is different from POET's situation: SpaceX calls Filtronic a reliable strategic partner, Filtronic is cash-flow and EBITDA positive with SpaceX funding its R&D, and management scores 96/100 on his self-built framework versus 19/100 for POET. Says he's ready to make Filtronic his second-highest holding if the price is pushed below 200.
-
28 Apr 26
Introduces his new 5-category, 100-point management-integrity framework, explaining that standard institutional frameworks (McKinsey, Morgan Stanley, BCG, Morningstar) unfairly penalize high-growth pre-profit companies by focusing on ROI/FCF/dividends. Shares example scores and offers to run the framework for followers who lack a paid LLM subscription.
-
27 Apr 26
Says he's in the same position as the parent poster (who laid out a bearish thesis on POET following Marvell's contract termination) and confirms he decided to sell, reasoning that with near-zero trust in management there was no point waiting for their response, especially since management sat on the news for four days before disclosing it.
-
27 Apr 26
Explains, in response to a question, that whether Marvell owes compensation to the other company depends on the NDA's clauses, and that if Marvell violated it, Marvell could actually be the one exposed to a claim rather than the reverse.
-
27 Apr 26
Criticizes POET management for reacting more emotionally to the short report than retail investors did, calling it disappointing.
-
27 Apr 26
Sold entire POET position at $8 (avg cost $5.8, +38%) after Marvell abruptly cancelled the multi-year supply agreement citing an NDA breach; believes Marvell has an in-house alternative via its Polariton acquisition, so the short-term catalyst (Celestial AI order confirmation) is gone. States the short report didn't break his thesis, but management's handling did.
-
27 Apr 26
Believes Marvell's cancellation is less about dissatisfaction and more about having an in-house alternative, pointing to its Polariton acquisition which does similar work to POET's tech.
-
27 Apr 26
Expects Marvell will redesign its hardware to no longer need POET's technology.
-
27 Apr 26
Explains that Celestial AI's hardware is designed around POET's patented optical interposer, so Marvell's customers will likely need to redesign part of their hardware.
-
27 Apr 26
Questions whether the broad sell-off is really being driven by POET's news, since non-photonics stocks are down too.
-
27 Apr 26
Clarifies that POET's specific delivery-date disclosure was new, confidential information, not already public.
-
27 Apr 26
POET drops almost 50% after Marvell cancels all Celestial AI orders following an NDA breach; author is unsettled but not selling his shares, taking some comfort that the cancellation isn't about the technology itself.
-
27 Apr 26
Reacts with surprise to Marvell cancelling its order with POET.
-
27 Apr 26
Says POET is still mainly pre-revenue and a bet on technology execution; more room to run if they execute, but the asymmetry shrinks the higher it goes.
-
26 Apr 26
Explains not all details about the Marvell/POET situation were public, since POET's specific delivery-date disclosure was new and confidential.
-
26 Apr 26
Argues short reports have lost their power to scare investors now that AI and X make research accessible; cites POET's 125% rally since its short report as proof retail investors are doing real due diligence.
-
24 Apr 26
Gives a long-term minimum price target of $30 for POET if its R&D pans out, while noting significant remaining uncertainty.
-
24 Apr 26
Says he called the bottom on $POET and is now up 200% since buying.
-
22 Apr 26
Added to POET at $4.9, bringing his average cost to $5.8, making it one of his fastest doublers; cites the CFO confirming purchase orders far in excess of $5 million as reason to believe it's just the beginning.
-
21 Apr 26
Highlights three recent buys that have surged in the last three weeks — HIMS +62.5%, OUST +73.8%, POET +114% — and says it's only the beginning.
-
20 Apr 26
POET up 22% after announcing a US redomicile plan that counters Wolfpack Research's short thesis on PFIC tax consequences; congratulates those who held or bought the dip.
-
16 Apr 26
Reports strong gains on HIMS, OUST, and POET bought two weeks earlier.
-
14 Apr 26
Says he'll load more POET if it drops below $5.50.
-
14 Apr 26
POET drops 7.5% after a Wolfpack Research short report; he isn't worried, expects Q3 earnings in 5 months to be the real catalyst, and notes institutions typically close most short positions well before then.
-
12 Apr 26
Lays out a broad catalyst calendar across his sector watchlist spanning Q2 2026 through Q3 2027, covering scaling, energization, acquisition closes, product shipments, launches, and constellation milestones for a wide range of AI infrastructure, space, and defense names.
-
12 Apr 26
Says he keeps buying POET below $6, same as the person he's replying to.
-
11 Apr 26
Tells a follower he thinks $POET's Q3 earnings would be the confirmation point to buy.
-
11 Apr 26
Bullish on both $POET and $OUST heading into Q3 2026, which he calls big for both. $POET is a riskier pre-revenue photonics play with first revenue expected Q3 2026 and unlimited upside but high execution risk. $OUST is a safer LiDAR sensor play for autonomous vehicles/robots that benefits from the Chinese-supplier ban under the Safe Act (June 2026); expects first positive signs in Q3 2026 and plans to keep buying dips of both. Charts show POET +42.8% and OUST +24.49% over the past ~2 weeks.
-
10 Apr 26
Confirms in reply to a comment about rotating MRVL into POET that he also owns POET.
-
05 Apr 26
Monthly portfolio update: up 6.9% in March, led by PL, PLTR, RKLB and AMPX; initiated four new positions (OUST, POET, MRVL, SK Hynix), added to HIMS; TMDX, HOOD, FLNC and IREN declined; plans to cut cash from 20% to 10% and consolidate from 16 to 11 holdings.
-
04 Apr 26
Pushes back that POET's CEO having a PhD doesn't count toward his founder-led exception rule, since POET's CEO is not the founder.
-
02 Apr 26
Confirms POET was included in a list simply because it's one of his investments, unrelated to any space theme.
-
02 Apr 26
Bullish on space stocks broadly, highlighting PL's strong outperformance today as part of a sector re-rating.
-
01 Apr 26
Wryly hopeful about POET's long troubled history finally paying off this time.
-
01 Apr 26
Long, high-conviction, pre-revenue thesis on POET: unspectacular earnings but a strong cash cushion versus liabilities limits downside, while its optical interposer targets a fast-growing photonics TAM; sees limited downside and large upside despite management's low transparency.
-
31 Mar 26
Explains POET isn't expected to show first real revenue until late 2026, offered as a tentative reason for why certain deals/calls aren't happening yet.
-
31 Mar 26
Notes a downside of POET is the lack of a conference call, meaning investors just have to read whatever disclosure is published.
-
31 Mar 26
Sees POET pumping ahead of earnings as a good sign, and views the NVDA-MRVL collaboration as validating POET's business case.
-
31 Mar 26
Made three buys the prior day — HIMS at $18.70, OUST at $16.70, and POET at $4.90 — and reiterates HIMS looks very undervalued right now.
-
31 Mar 26
Previews POET's earnings tonight: expects no meaningful revenue yet, ~$350M cash and no debt for multi-year runway, and will focus on commentary about partnerships (Foxconn Interconnect, Luxshare, Semtech, Mitsubishi Electric) as evidence the wafer-scale passive alignment thesis is becoming commercially real in a $28.75B silicon photonics market.
-
30 Mar 26
Added to his POET position today at $4.90.
-
20 Mar 26
Posts YTD performance of pre-revenue stocks (OKLO, NNE, ASTS, JOBY, ACHR, QS, LUNR, POET, NUVL), concluding investors are de-risking from speculative names.
-
19 Mar 26
Asks whether AAOI still has upside after its run, and discloses he has recently invested in POET.
-
16 Mar 26
Notes POET up 6% on a strategic partnership with LITEON to co-develop next-gen optical communication modules using POET's Optical Interposer tech, with prototypes by late 2026 and high-volume production targeted for 2027.
-
12 Mar 26
Asks followers for input on his $HOOD position (up 122% over a year, ~5% of portfolio), questioning if the company has lost its edge. Attached portfolio screenshot reveals his broader top holdings and allocation weights.
-
11 Mar 26
Reveals he bought POET, MRVL, OUST, and SK Hynix.
-
11 Mar 26
Discusses photonics research; sees POET's cash pile as limiting downside with explosive upside, and views MRVL's recent acquisitions as a safe way to get exposure.
-
11 Mar 26
Confirms he bought POET because its $335M cash position limits downside while leaving explosive upside if things go well.
-
11 Mar 26
Expects some manufacturing concerns for POET early on since it's still pre-revenue.
-
11 Mar 26
Announces four new buys this week: OUST as an asymmetric physical-AI/LiDAR bet, SK Hynix for HBM memory dominance, POET for optical interposer technology, and MRVL for the compute-to-connectivity/optical DSP shift.
-
11 Mar 26
Gives a balanced take on POET's technology: the physics/prototypes are validated, but commercial execution at scale is not proven yet; sees limited downside given the $1B valuation and recent $225m raise, but says the company still has a lot to prove with zero revenue.
-
11 Mar 26
Opened a new position in POET at $6.52, laying out a long bull thesis on POET's wafer-scale photonics manufacturing, its de-risked balance sheet (~$350m cash, minimal debt), commercial validation (production orders, tier-one partners) and a reverse-DCF valuation case for major multi-year upside.
-
07 Mar 26
Names POET as his favorite stock currently trading under $10.
-
02 Mar 26
Quantum Computing Inc is pivoting from pure research to physical manufacturing; revenue is still tiny (just under $200k) but tripled YoY, and a $750M raise gives a long runway. New chip factory opened, a second planned, Luminar Semiconductor acquired to bring supply chains in-house, and a new AI partnership with $POET shows commercial promise. Stock slipped 1.5% after earnings despite these moves.
-
27 Feb 26
Lists companies he plans to research over the weekend: IBRX, AAOI, UAMY, LITE, POET, TE, AMPX.
-
13 Feb 26
Agrees that photonics names (LITE, COHR, AAOI, ALMU, POET) should have been included in his list.